Anti-CD137 molecules and use thereof
ZA202201011BActive Publication Date: 2026-08-26ADAGENE INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ZA202201011
- Authority / Receiving Office
- ZA · ZA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-08-21
- Filing Date
- 2022-01-21
- Publication Date
- 2026-08-26
- Estimated Expiration
- 2042-01-21
Abstract
Provided are antibodies that bind to human CD137 or antigen binding fragments thereof, nucleic acid encoding the same, therapeutic compositions thereof, and their use to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, such as tumor immunity, and for the treatment of cancer.
Need to check novelty before this filing date? Find Prior Art